SYDNEY NICHOLS: Open Payments
NPI 1740754076 · ARLINGTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,664 in 94 payments from 17 companies in 2025. Trend: 2023 $2,419 · 2024 $1,321 · 2025 $1,664
Food & beverage: $1,575Education: $89
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 42 | $626 |
| Regeneron Healthcare Solutions, Inc. | 11 | $196 |
| Janssen Biotech, Inc. | 8 | $177 |
| Madrigal Pharmaceuticals | 8 | $146 |
| Phathom Pharmaceuticals, Inc. | 4 | $80 |
| Ipsen Biopharmaceuticals, Inc | 3 | $74 |
| Lilly USA, LLC | 3 | $73 |
| EVOKE PHARMA, INC. | 3 | $49 |
| Braintree Laboratories, Inc. | 1 | $39 |
| Celltrion USA Inc. | 2 | $33 |
Products named: RINVOQ, DUPIXENT, TREMFYA, REZDIFFRA, SKYRIZI, LINZESS, CREON, VOQUEZNA.
Industry payments across TX — which companies pay providers there.
